Physician profile
Michelle Talbert
NPI 1225477540
$1,153.17
in general payments reported to CMS, 2019-2025
14 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $141 · 2022: $124 · 2023: $256 · 2024: $311 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $889.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $358.46 | 2023-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Kaleo, INC. | $219.31 | 2021-2023 | Auvi-Q |
| Cranial Technologies, INC | $188.93 | 2022-2025 | Doc Band |
| Pfizer INC. | $117.92 | 2023-2025 | |
| Kyowa Kirin, INC. | $44.40 | 2025 | |
| Sanofi Pasteur INC. | $44.31 | 2021 | |
| Verrica Pharmaceuticals INC. | $42.58 | 2024 | Ycanth |
| Tris Pharma INC | $31.39 | 2025 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $28.18 | 2022-2024 | Pediarix, Rotarix, Bexsero |
| Collegium Pharmaceutical, INC. | $20.99 | 2025 | Jornay Pm |
| Seqirus USA INC | $17.95 | 2023 | Flucelvax Quadrivalent |
| Lnhc, INC | $15.14 | 2025 | Zelsuvmi |
| Genentech USA, INC. | $11.85 | 2022 | |
| Sobi, INC | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Talbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.